Posted by Boston, USA: With $2.7 million in seed funding, LogicFlo to bring AI workforce to life sciences experts. The Boston based startup LogicFlo AI announced a $2.7 million in seed funding round to scale its intelligent agent platform across the pharmaceutical, biotech, and medical tech industries.
Lightspeed led the round with participation from leading healthcare and enterprise AI investors. The seed funding will drive product expansion, team growth, and deeper deployments with global life sciences organisations, including a Fortune 500 customer already under contract.
LogicFlo to bring AI workforce to life sciences experts
Founded by Udith Vaidyanathan and Arun Ramakrishnan, LogicFlo holds a unique vision for AI in regulated industries. LogicF platform gives every life sciences expert their own team of intelligent agents – AI collaborators designed to execute high-stakes, high-compliance tasks under human guidance, turning each specialist into the CEO of their own workflow.
“While the rest of the world is focused on automation instead of people, we are building automation for people,” said Udith Vaidyanathan, LogicFlo’s co-founder and CEO. “LogicFlo puts experts firmly at the centre. The goal is to let the brightest people in life sciences do what only they can do – drive medical science forward and help elevate standard of care. “
Vaidyanathan previously steered key business units from inside Abbott’s CEO office before dropping out of Harvard Business School to build LogicFlo AI.
Arun Ramakrishnan, Co-Founder and CTO, previously led deep learning efforts at Intuitive Surgical, where he built high-precision AI models for the Da Vinci robotic system deployed in real-world surgeries.
“Traditional automation has failed life sciences because it’s too rigid, too brittle, and too out of touch with how people actually work,” explained Arun Ramakrishnan, Co-Founder at LogiFlo. “Our agents are different. They’re intelligent, composable, production-ready, and they understand the nuance of scientific work.”
While most life sciences software remains focused on platforms that store information but don’t do the work, LogicFlo introduces a layer where users interact directly with intelligent agents that can take instruction, act, and deliver results. For the first time, work itself moves into a unified system of engagement, marking a paradigm shift in how knowledge work happens.
The platform is already deployed across medical affairs, regulatory, commercial, and quality teams at global pharmaceutical and medical device companies.
Deployments typically begin with 20–30 active users and scale organically as teams experience the results. The impact is dramatic: medical writing outputs that took weeks now take minutes – with up to 2000x reduction in time to first draft – and response timelines for medical information requests have collapsed from 1-2 weeks to 1-2 days.
“We’re thrilled to back LogicFlo AI as they revolutionize how life sciences and biotech organizations operate. Their AI agent platform empowers medical affairs and commercial teams to build agentic workflows across diverse use cases, dramatically boosting productivity.,” commented Rohil Bagga, VP of Investments, Lightspeed.